Drug profile · INN
fedratinib hydrochloride
INREBIC
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
fedratinib hydrochloride (INREBIC) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN fedratinib hydrochloride
Brand INREBIC
Route ORAL
Formulation CAPSULE
Frequently asked questions
What is fedratinib hydrochloride?
fedratinib hydrochloride (INREBIC) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for fedratinib hydrochloride?
INREBIC is a marketed brand name for fedratinib hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fedratinib hydrochloride?
fedratinib hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.